23andMe’s Saliva Collection Kit/Personal Genome Service

June 2014: A federal judge granted the company’s motion to compel all of the plaintiffs in related cases to arbitrate their claims and dismissed plaintiffs’ claims When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. For more information about the status, click here.

March 2014: This case was transferred to another California court. (14-cv-1167, N. D. CA.)

November 2013: A class-action lawsuit was filed against 23andMe, Inc. alleging that the company falsely advertises its Saliva Collection Kit/Personal Genome Service (PGS). Among other things, plaintiffs claim that the company’s advertisements represent that PGS will provide consumers with information about their health – including “reports on over 240+ conditions and traits” and “personalized recommendations” – without analytical or clinical validation to support such claims. In addition, the complaint alleges that the company’s advertising campaigns violate the Federal Food, Drug and Cosmetic Act. (Casey et al v. 23andMe, Inc. and Does 1-100, Case No. 13-cv-2847, S. D. CA.).

For more information about other class-action lawsuits filed against 23andMe and TINA.org’s coverage of the company, click here.